VentureBeat

Fluidigm raises another $7.5M for stem-cell analysis chips

Fluidigm, which makes chips that for genetics lab, has raised $7.5 million in new equity, according to VentureWire. That’s part of a new $18.5 million round that the South San Francisco, Calif.
VentureBeat

Fluidigm raises $10.7M to enhance stem-cell studies

Fluidigm, maker of chips used in genetic analysis systems, has raised $10.7 million of a targeted $14 million round of debt, warrants, rights and securities, according to a regulatory filing with the ...
technologynetworks

Fluidigm Europe Announces a new Technical Poster Describing its Access Array™ Chip Technology

Fluidigm Europe has announced a new technical poster describing how its Access Array™ chip technology has been used by the Core Genotyping facility at the National Cancer Institute (Bethesda, MD) to ...
technologynetworks

A Fundamental Breakthrough for Single-Cell Gene Expression Analysis

The Fluidigm BioMark™ System revolutionizes how biologists can conduct single-cell gene expression experiments. Using microfluidic chips, the BioMark System features low input requirements and ...
Business Wire

Fluidigm Corporation Prices Initial Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced the pricing of its initial public offering of 5,558,333 shares of its common stock at a price to the public of $13.50 ...